Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 23)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A XOMA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Pechala's Reports Lubomir Pechala XOMA LTD (XOMA=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for XOMA 13 $25 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala XOMA CORP (XOMA=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: XOMA LTD 5 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A XOMA Ltd 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala XOMA CORP (XOMA=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: XOMA -- XOMA 1 $4 View Abstract
Next 13

Independent Reports (Showing 1 to 10 of 23)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A XOMA: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
8-Feb-10 Pechala's Reports Lubomir Pechala XOMA LTD (XOMA=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract
8-Feb-10 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for XOMA 13 $25 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract
7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract
7-Feb-10 Pechala's Reports Frantisek Pechala XOMA CORP (XOMA=US) 12-months forecast 1 $15 View Abstract
7-Feb-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: XOMA LTD 5 $25 View Abstract
6-Feb-10 Standard & Poor's Quantitative Report N/A XOMA Ltd 6 $25 View Abstract
6-Feb-10 Pechala's Reports Lubomir Pechala XOMA CORP (XOMA=US) 2-weeks forecast 1 $10 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: XOMA -- XOMA 1 $4 View Abstract
Next 13

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.